We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
+$159M
Cap. Flow %
3.95%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTX icon
301
Context Therapeutics
CNTX
$47.3M
$324K 0.01%
308,758
SMCI icon
302
Super Micro Computer
SMCI
$19.8B
$305K 0.01%
+10,000
New +$363K
AMC icon
303
AMC Entertainment Holdings
AMC
$2.25B
$302K 0.01%
75,994
-1,034
-1% -$4.54K
CYPH
304
Cypherpunk Technologies Inc
CYPH
$73.2M
$302K 0.01%
105,108
-60,000
-36% -$178K
DYN icon
305
Dyne Therapeutics
DYN
$4.73B
$296K 0.01%
12,584
-6,734
-35% -$199K
ALKS icon
306
Alkermes
ALKS
$8.22B
$279K 0.01%
9,710
-40,251
-81% -$1.16M
SEPN
307
Septerna Inc
SEPN
$1.72B
$278K 0.01%
+12,118
New +$287K
PANW icon
308
Palo Alto Networks
PANW
$297B
$257K 0.01%
+1,412
New +$267K
ARDX icon
309
Ardelyx
ARDX
$998M
$252K 0.01%
49,701
-11,035
-18% -$61K
HAPN
310
Happen Inc
HAPN
$2.24B
$243K 0.01%
+15,000
New +$221K
MGNI icon
311
CALL
Magnite
MGNI
$3.61B
$241K 0.01%
107,000
FTNT icon
312
Fortinet
FTNT
$117B
$240K 0.01%
+2,537
New +$226K
NERV icon
313
Minerva Neurosciences
NERV
$206M
$238K 0.01%
107,256
INTU icon
314
Intuit
INTU
$90.1B
$237K 0.01%
+377
New +$241K
SCYX icon
315
SCYNEXIS
SCYX
$53.9M
$236K 0.01%
24,424
+4,404
+22% +$45.7K
ZTO icon
316
ZTO Express
ZTO
$17.9B
$231K 0.01%
+11,800
New +$259K
PYXS icon
317
Pyxis Oncology
PYXS
$233M
$228K 0.01%
+146,400
New +$422K
BDTX icon
318
Black Diamond Therapeutics
BDTX
$111M
$224K 0.01%
104,560
+13,854
+15% +$39.7K
IWM icon
319
PUT
iShares Russell 2000 ETF
IWM
$82.9B
$216K 0.01%
+36,000
New +$8.21M
VERU icon
320
Veru
VERU
$38M
$215K 0.01%
32,986
CRVS icon
321
Corvus Pharmaceuticals
CRVS
$1.15B
$214K 0.01%
+40,000
New +$299K
CHTR icon
322
PUT
Charter Communications
CHTR
$18.4B
$208K 0.01%
8,400
IMUX icon
323
Immunic
IMUX
$207M
$205K 0.01%
20,458
+9,689
+90% +$122K
SRRK icon
324
CALL
Scholar Rock
SRRK
$6.28B
$203K 0.01%
+40,000
New +$1.3M
ZURA icon
325
Zura Bio
ZURA
$559M
$202K 0.01%
80,912

Similar funds

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $159M of net new capital in Q4 2024, opening 130 new positions and adding to 130 existing holdings. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was US Steel, an estimated $62.2M trimmed.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.